ANDA 211629, held by Ani Pharms. Aminocaproic Acid.
As of Nov 15, 2026, ANDA 211629 (Aminocaproic Acid), held by Ani Pharms, was first approved by FDA on Dec 14, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 14, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Aminocaproic Acid500MG ยท tablet;oral | Aminocaproic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
